Targeted next-generation sequencing in the diagnosis of neurodevelopmental disorders

Clin Genet. 2015 Sep;88(3):288-92. doi: 10.1111/cge.12492. Epub 2014 Nov 13.

Abstract

We developed a next-generation sequencing (NGS) based mutation screening strategy for neurodevelopmental diseases. Using this system, we screened 284 genes in 40 patients. Several novel mutations were discovered. Patient 1 had a novel mutation in ACTB. Her dysmorphic feature was mild for Baraitser-Winter syndrome. Patient 2 had a truncating mutation of DYRK1A. She lacked microcephaly, which was previously assumed to be a constant feature of DYRK1A loss of function. Patient 3 had a novel mutation in GABRD gene. She showed Rett syndrome like features. Patient 4 was diagnosed with Noonan syndrome with PTPN11 mutation. He showed complete agenesis of corpus callosum. We have discussed these novel findings.

Keywords: Baraitser-Winter syndrome; DYRK1A; GABRD; next-generation sequencing.

Publication types

  • Case Reports
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Actins / genetics
  • Child
  • Child, Preschool
  • Dyrk Kinases
  • Female
  • High-Throughput Nucleotide Sequencing*
  • Humans
  • Magnetic Resonance Imaging
  • Male
  • Mutation
  • Neurodevelopmental Disorders / diagnosis*
  • Neurodevelopmental Disorders / genetics*
  • Polymorphism, Single Nucleotide
  • Protein Serine-Threonine Kinases / genetics
  • Protein Tyrosine Phosphatase, Non-Receptor Type 11 / genetics
  • Protein-Tyrosine Kinases / genetics
  • Receptors, GABA-A / genetics

Substances

  • Actins
  • GABRD protein, human
  • Receptors, GABA-A
  • Protein-Tyrosine Kinases
  • Protein Serine-Threonine Kinases
  • PTPN11 protein, human
  • Protein Tyrosine Phosphatase, Non-Receptor Type 11